Commentary - (2025) Volume 9, Issue 4
Received: 02-Aug-2025, Manuscript No. jcre-26-187217;
Editor assigned: 04-Aug-2025, Pre QC No. P-187217;
Reviewed: 18-Aug-2025, QC No. Q-187217;
Revised: 25-Aug-2025, Manuscript No. R-187217;
Published:
01-Sep-2025
, DOI: 10.37421/2795-6172.2025.9.318
Citation: Horvat, Katarina. ”Optimizing Postoperative Nausea Vomiting Management Strategies.” J Clin Res 09 (2025):318.
Copyright: © 2025 Horvat K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Postoperative nausea and vomiting (PONV) remains a prevalent and distressing complication following surgical procedures, significantly impacting patient recovery and overall surgical experience. The management of PONV necessitates a thorough understanding of various antiemetic agents and their comparative efficacies. This introduction aims to delineate the landscape of research surrounding PONV prophylaxis and treatment, drawing from a selection of key studies that highlight different facets of this clinical challenge. One critical aspect of PONV management involves the direct comparison of different antiemetic drugs. A randomized controlled trial by Afshari et al. [1] evaluated the efficacy and safety of ondansetron versus dexamethasone in preventing PONV after laparoscopic cholecystectomy. Their findings provided crucial data for clinical decision-making in anesthesia and surgical care, suggesting differential effectiveness and side-effect profiles that influence preferred treatment strategies. Further exploring the spectrum of antiemetic options, Kovac et al. [2] investigated the role of different antiemetic classes by comparing a serotonin antagonist with a dopamine antagonist in preventing PONV. This research underscored the importance of drug selection based on patient risk factors and surgical procedures, offering insights into optimizing PONV prophylaxis and potentially reducing the need for rescue antiemetics. Recognizing that monotherapy may not always suffice, Zhou et al. [3] conducted a systematic review and meta-analysis on combination therapy for PONV prevention. Their work examined the synergistic or additive effects of combining agents from different pharmacological classes, exploring whether combination therapy offers superior efficacy compared to monotherapy, particularly in high-risk patients. Beyond the choice of agents, the timing of administration is a crucial consideration in PONV management. Shin et al. [4] addressed this by investigating whether proactive prophylaxis or reactive treatment yields better outcomes for PONV. Their randomized controlled trial compared the effectiveness of agents administered at different perioperative time points, providing guidance on optimal drug delivery strategies to maximize PONV prevention. Understanding the fundamental mechanisms of action of antiemetic drugs is also vital for informed clinical practice. Kwon et al. [5] delved into the specific mechanisms of action for commonly used antiemetic agents, exploring their target receptors and signaling pathways involved in PONV. This molecular insight contributes to a more personalized approach to PONV management. The impact of patient-specific factors on antiemetic efficacy is another area of significant interest. Park et al. [6] assessed how patient characteristics, such as a history of PONV, motion sickness, and gender, influence the effectiveness of antiemetic agents. Their study aimed to identify which agent performs better in different patient subgroups, crucial for optimizing PONV prophylaxis. From an economic perspective, the cost-effectiveness of antiemetic strategies is a significant consideration for healthcare systems. Radic et al. [7] conducted a systematic review on the cost-effectiveness of prophylactic antiemetic drugs, considering drug cost, length of hospital stay, and the need for additional treatments, offering valuable economic perspectives. The incidence and management of PONV can also vary across different surgical specialties. Lia et al. [8] systematically reviewed the incidence and risk factors of PONV in diverse surgical procedures, comparing the efficacy of antiemetic agents across these settings. This provides tailored recommendations for various surgical contexts. Finally, the duration of action and the need for repeat dosing of antiemetic agents are important for sustained PONV control. Wang et al. [9] compared two agents focusing on their duration of action and the necessity for repeat administrations in preventing PONV, which is crucial for managing patients at risk of delayed PONV.
Postoperative nausea and vomiting (PONV) continues to pose a significant challenge in the perioperative setting, impacting patient comfort and recovery. A comprehensive understanding of available antiemetic strategies is essential for effective management. This section details various studies that explore different dimensions of PONV care. Afshari et al. [1] conducted a randomized controlled trial comparing ondansetron and dexamethasone for PONV prevention after laparoscopic cholecystectomy. Their work aimed to determine the efficacy and safety profiles of these agents, offering critical data to guide clinical decisions in anesthesia and surgical care by highlighting differential effectiveness and side-effect profiles. Kovac et al. [2] investigated the comparative efficacy of different antiemetic classes, specifically a serotonin antagonist and a dopamine antagonist, in preventing PONV. Their study emphasized the importance of tailoring drug selection based on patient risk factors and surgical procedures, contributing to optimized PONV prophylaxis and reduced reliance on rescue medications. Addressing the potential benefits of combined pharmacological approaches, Zhou et al. [3] performed a systematic review and meta-analysis evaluating combination therapy for PONV prevention. This research explored whether combining antiemetic agents from different classes yields superior efficacy compared to monotherapy, particularly for patients at higher risk. Shin et al. [4] examined the impact of administration timing on PONV management through a randomized controlled trial comparing prophylactic versus rescue antiemesis. This study focused on the effectiveness of two specific agents administered at different perioperative intervals, providing insights into optimal drug delivery strategies. Understanding the underlying physiological and pharmacological mechanisms is key to developing targeted therapies. Kwon et al. [5] explored the mechanisms of action of antiemetic drugs, detailing their target receptors and signaling pathways involved in PONV. This fundamental research supports a more personalized and effective approach to PONV management. Personalized medicine is increasingly important in optimizing treatment outcomes. Park et al. [6] assessed the influence of patient-specific factors, including a history of PONV, motion sickness, and gender, on the effectiveness of antiemetic agents. Their findings are vital for tailoring PONV prophylaxis to individual patient profiles. The economic implications of healthcare interventions are critical for resource allocation. Radic et al. [7] presented a systematic review on the cost-effectiveness of prophylactic antiemetic drugs, considering not only clinical outcomes but also financial aspects such as drug costs and hospital stay duration. Surgical context plays a significant role in PONV incidence and management. Lia et al. [8] conducted a systematic review and meta-analysis to investigate PONV incidence and risk factors across different surgical procedures, also comparing antiemetic efficacy in these varied settings to inform procedure-specific recommendations. Ensuring sustained PONV control throughout the postoperative period is essential. Wang et al. [9] focused on the duration of action of antiemetic agents, comparing their longevity and the need for repeat dosing in preventing PONV, which is crucial for managing patients susceptible to delayed symptoms. Finally, Lee et al. [10] broadened the scope by evaluating the impact of antiemetic agents on patient-reported outcomes beyond nausea and vomiting, including satisfaction with pain management, early ambulation, and overall recovery experience, thus providing a holistic perspective on patient well-being post-surgery.
This compilation of studies examines various strategies for managing postoperative nausea and vomiting (PONV), a common post-surgical complication. Research includes comparative efficacy studies of different antiemetic agents, investigations into combination therapies, and the impact of administration timing. The influence of patient-specific factors, surgical procedures, and the underlying mechanisms of action of antiemetics are also explored. Economic considerations through cost-effectiveness analyses and the effect of antiemetics on broader patient-reported outcomes like satisfaction and recovery are also highlighted. The overarching goal is to optimize PONV prophylaxis and treatment for improved patient care.
None
None
Journal of Clinical Research received 11 citations as per Google Scholar report
